Navigation Links
Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/27/2008

s planned New Drug Application

submission to the FDA and for commercialization of lorcaserin after

regulatory marketing approval. The agreements included a long-term

supply agreement for Arena's purchase of lorcaserin active

pharmaceutical ingredient, or API, the purchase of certain finishing

facility assets and technology, including fixtures, equipment, other

personal property and real estate assets, a contract manufacturing

agreement whereby Arena will manufacture certain products for

Siegfried, and a services agreement.

-- Reported positive Phase 1a clinical trial results of APD791, Arena's

oral, internally discovered drug candidate intended for the treatment

and prevention of arterial thromboembolic diseases, and initiated a

Phase 1b clinical trial to further evaluate this drug candidate.

-- Announced that initial clinical trial results for APD668, an oral drug

candidate discovered by Arena and investigated for the treatment of

type 2 diabetes under its partnership with Ortho-McNeil, suggest that

the Glucose-Dependent Insulinotropic Receptor, or GDIR, may improve

glucose control in patients with type 2 diabetes. Based on the data

from those studies, Ortho-McNeil put APD668 on hold and has advanced a

potentially more potent Arena-discovered GDIR agonist into preclinical

development.

Outlook for 2008

Arena expects to use cash, cash equivalents and short-term investments of approximately $190 to $210 million for its operating activities in 2008 and approximately $38 to $44 million for capital expenditures, which includes the cash payable at closing for the acquisition from Siegfried Ltd of a drug product finishing facility and related assets, which closed in January 2008. This assumes that Arena, and not a partner, continues to advance and fund its planned 20
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
3. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
4. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
5. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007
7. Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results
8. Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors
10. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
11. Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 Shimadzu ... new UV-1280 multipurpose UV-visible spectrophotometer. Offering wavelength scanning ... instrument is ideal for applications in a variety ... science. , The user-friendly UV-1280 enables intuitive operation, ...
(Date:1/22/2015)... GEA Niro Soavi the leader in high ... PandaPLUS 2000, which is ideal for new applications for ... disruption . This compact laboratory homogenizer is the perfect ... food additives and ingredients as well as for the ...
(Date:1/22/2015)... January 21, 2015 Cambridge Semantics, the leading ... today announced that 2014 was a record-breaking year across the ... of the Anzo Smart Data Platform and our Smart Data ... insights from diverse data which led to record growth for ...
(Date:1/22/2015)... Johnston, RI (PRWEB) January 22, 2015 ... State , The growing team of brand-neutral, independent consultants, ... CIO Philip Rogers explained that over the years, his ... including , Moroso, Town of Plainfield, as well as ...
Breaking Biology Technology:Shimadzu’s New Monitored Single-Beam UV-Vis Spectrophotometer Offers Comprehensive Measurement Options in a Compact Body 2GEA Niro Soavi Announces the PandaPLUS 2000 Homogenizer for Processing New Applications for Nanoemulsions and Cell Disruption 2Cambridge Semantics Announces Record Results for 2014 2Protocol Networks Brings Independent Technology Consulting to the Constitution State 2
... Watch out baby boomers, those 8th graders can talk ... curriculum at the tender age of 13, thanks to ... ,The Information Technology Academy (ITA), a joint venture of ... PEOPLE Program (Pre-college Enrichment Opportunity Program for Learning Excellence), ...
... Midwest has been approached by a variety of country ... regional biotech communities. These groups include: , ,1. The Swiss ... Singaporeans ,7. The Danish , ,None, however, have taken ... , ,In at least two previous columns, you have ...
... SoftSwitching Technologies , a high-technology spin-off of the University ... Thursday during the biggest blackout the nation has ever ... said, Near-simultaneous events were recorded in New York and ... spread across the northeastern United States, with the I-Grid ...
Cached Biology Technology:Joint Venture Trains Minority Students for IT Careers 2Joint Venture Trains Minority Students for IT Careers 3Japanese Continue Relentless Biotech Stake in Midwest 2Japanese Continue Relentless Biotech Stake in Midwest 3Japanese Continue Relentless Biotech Stake in Midwest 4Japanese Continue Relentless Biotech Stake in Midwest 5Japanese Continue Relentless Biotech Stake in Midwest 6Japanese Continue Relentless Biotech Stake in Midwest 7Japanese Continue Relentless Biotech Stake in Midwest 8Japanese Continue Relentless Biotech Stake in Midwest 9Local Company Records Blackout with Web-Based Monitoring System 2Local Company Records Blackout with Web-Based Monitoring System 3
(Date:1/22/2015)... 2015   EyeLock, Inc. , a market leader of iris-based ... Gerber to the new role of Senior Vice President ... development of mobile platforms and wearable solutions for EyeLock,s technologies. ... in the semiconductor industry to his role at EyeLock, with ...
(Date:12/24/2014)... , Dec. 23, 2014  Since its launch in December 2014, the ... eliminate the pain of trying to remember their usernames and ... fused to their smartphones. To assist people who have struggled ... company that created 1U and focuses on redefining identity, announced ...
(Date:12/22/2014)... Research and Markets ( http://www.researchandmarkets.com/research/fx4bg3/the_global ) ... Global Watermarking and Fingerprinting Markets" report to ... This insight provides an overview ... markets. Watermarking aims to control and monitor piracy ...
Breaking Biology News(10 mins):EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3The Global Watermarking and Fingerprinting Markets 2
... evidence of social behavior among many species of animals, both ... lions live in packs, and hornets construct nests that can ... our feet, it appears that nematodesalso known as roundwormsare having ... was unknown how the worms communicate to one another when ...
... years, the growing demand for organic food products has led ... Faculty of Science, University of Copenhagen, a European research project ... origin of a food product and deciding whether or not ... such as olive oil, coffee and wine are sold at ...
... two new frog species in New Guinea, one of which is ... in the Jan. 11 issue of the online journal PLoS ... Austin of Louisiana State University. The new smallest vertebrate species ... Papua New Guinea, where it was found. The adult body size ...
Cached Biology News:Worm seeks worm: Caltech researchers find chemical cues driving aggregation in nematodes 2Worm seeks worm: Caltech researchers find chemical cues driving aggregation in nematodes 3Research prevents eco-fraud 2Research prevents eco-fraud 3
... (1995) • This book is unique ... and molecular techniques currently used in ... analysis of virus-specific antibodies and clinical ... covering immunoassays, blotting and hybridization procedures, ...
...
... The TOPO Cloning Kits for Sequencing allow ... The kits contain TOPO Cloning vectors with primer ... from the PCR product insertion site. This minimizes ... be read before reaching the sequence of your ...
Blot Paper 7 x 8.5cm semi-dry western blots (order number RB-400)...
Biology Products: